BCL2 and breast carcinoma: Specifically in the context of breast cancer, Mcl-1 has genetic or mRNA upregulation in 16/58 (28%) of human breast cancer cell lines as curated by the CCLE (Figure 3), while Bcl-2 is only aberrantly upregulated in 2/58 cases (3%) [54].